BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6423185)

  • 1. Intravenous infusion of frusemide as treatment for ascites in malignant disease.
    Amiel SA; Blackburn AM; Rubens RD
    Br Med J (Clin Res Ed); 1984 Apr; 288(6423):1041. PubMed ID: 6423185
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Treatment of ascites.
    Naccarato R; Sturniolo GC; Farini R; D'Angelo A; Ossi E
    Lancet; 1974 Nov; 2(7890):1213. PubMed ID: 4139635
    [No Abstract]   [Full Text] [Related]  

  • 3. Ascites free-water dynamics in decompensated cirrhosis: effects of acute and chronic frusemide treatment.
    Milani A; Ciammella AM; Rossi L
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):763-7. PubMed ID: 7496866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
    Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
    Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of frusemide in refractory oedema.
    Lawson DH; Gray JM; Henry DA; Tillstone WJ
    Br Med J; 1978 Aug; 2(6135):476. PubMed ID: 678930
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous infusion of frusemide in refractory oedema [proceedings].
    Gray JM; Henry DA; Lawson DH; Tilstone WJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):461P. PubMed ID: 728311
    [No Abstract]   [Full Text] [Related]  

  • 7. Some observations in the management of acute renal failure by massive intravenous frusemide therapy.
    Chandra M; Agarwal SS; Mitra MK; Tandon NN; Gupta NN
    J Assoc Physicians India; 1975 Jul; 23(7):415-22. PubMed ID: 1194211
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    Tuttolomondo A; Di Raimondo D; Bellia C; Clemente G; Pecoraro R; Maida C; Simonetta I; Vassallo V; Di Bona D; Gulotta E; Ciaccio M; Pinto A
    PLoS One; 2016; 11(12):e0165443. PubMed ID: 27941973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive intravenous frusemide therapy in acute renal failure.
    Chandra M; Agarwal SS; Mitra NK; Gupta NN
    J Indian Med Assoc; 1975 Jan; 64(2):47-8. PubMed ID: 1133468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reasons for diuretic therapy of cirrhotic ascites].
    Parlapiano C; Paoletti V
    Minerva Med; 1985 Nov; 76(43):2043-6. PubMed ID: 3934593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myxedematous ascites].
    Aleksić IM
    Med Glas; 1972 Mar; 26(8):115-7. PubMed ID: 5080887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L; Candiori R
    Med Interna (Bucur); 1970 May; 22(5):573-92. PubMed ID: 5426383
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites.
    Goto A; Terai S; Nakamura M; Matsumoto M; Sakaida I
    Clin J Gastroenterol; 2015 Feb; 8(1):47-51. PubMed ID: 25475138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triamterene-frusemide combination in edematous patients].
    Cruz J; Mattar E; Cruz HM
    Hospital (Rio J); 1970 Jun; 77(6):1881-93. PubMed ID: 5312537
    [No Abstract]   [Full Text] [Related]  

  • 16. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
    Ventura E; Zeneroli ML
    Folia Endocrinol; 1969 Dec; 22(4):345-53. PubMed ID: 4329093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical program of therapy for ascitic edema in liver disease].
    Pupita F; Ansuini R; Frausini G
    Clin Ter; 1982 Jan; 100(2):115-33. PubMed ID: 7186421
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on furosemide: an effective oral saludiuretic for bilharzial ascites.
    Shafei AZ; Habib YA; el-Khangry HA; Abou-Khair SA; Abaza HH; Nibal AH
    J Trop Med Hyg; 1967 Dec; 70(12):286-92. PubMed ID: 6061451
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
    Marelli A; Bodini P; Reggiani A; Quinzani M; Dizioli P; Tonghini L
    Minerva Med; 1997 Mar; 88(3):109-15. PubMed ID: 9148226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous furosemide.
    Goenaga MA; Millet M; Sánchez E; Garde C; Carrera JA; Arzellus E
    Ann Pharmacother; 2004 Oct; 38(10):1751. PubMed ID: 15340122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.